Thorne HealthTech (THRN) Achieves Self-Affirmed GRAS Status for Nicotinamide Riboside Malate

July 19, 2022 4:20 PM EDT

Thorne HealthTech, Inc. (NASDAQ: THRN) today announced that it has achieved self-affirmed GRAS (Generally Recognized as Safe) status for its proprietary nicotinamide riboside malate (NRM) product.

Under the Federal Food, Drug and Cosmetic Act, GRAS is a regulatory classification term used to identify a food ingredient that is generally recognized among qualified experts as having been adequately shown to be safe under the conditions of its intended use.

Self-affirmed GRAS status requires that an ingredient undergo extensive quality and safety testing, as well as review by an independent outside expert panel. Based on extensive analysis, Thorne's NRM has been established as having a quality, safety, and purity profile equal to or superior to other forms of nicotinamide riboside currently on the market.

Thorne's NRM is also NSF Certified for Sport®, with each batch being independently tested by NSF. The NSF Certified for Sport® program provides the highest possible level of safety and testing to ensure products do not contain contaminants, banned substances, or masking agents, and that what is on the label matches what is in the product. Thorne's NRM product suite includes NiaCel®, Collagen Fit, ResveraCel®, and Advanced Nutrients, among other products.

"The benefits of nicotinamide riboside are vast, because researchers have found that nicotinamide riboside directly stimulates the production of energy in the body through NAD+, one of the most critical molecules in our bodies," said Thorne HealthTech CEO, Paul Jacobson. "Our proprietary nicotinamide riboside malate has proven to be best-in-class, and its new GRAS status is a major endorsement reinforcing the quality and safety of our product."



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News